Charanjit Dhillon
Direktor/Vorstandsmitglied bei OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Aktive Positionen von Charanjit Dhillon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Direktor/Vorstandsmitglied | 23.04.2021 | - |
| Independent Dir/Board Member | 23.04.2021 | - | |
Oxford Cannabinoid Technologies Ltd.
 Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Charanjit Dhillon
Ehemalige bekannte Positionen von Charanjit Dhillon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lorantis Ltd.
 Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Finanzdirektor/CFO | - | 01.10.2005 |
Ausbildung von Charanjit Dhillon
| University of Hertfordshire | Masters Business Admin |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Director/Board Member | 2 |
| Director of Finance/CFO | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lorantis Ltd.
Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Health Technology |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Charanjit Dhillon
- Erfahrung
